Eosinophilic esophagitis: A potential complication of sublingual immunotherapy

Introduction. Eosinophilic esophagitis (EoE) represents chronic, a local immune-mediated disease with symptoms of esophageal dysfunction and histologically eosinophil-predominant inflammation and requires immediate endoscopy. Male gender is a strong risk factor. Case report. We presented a case of a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Knežević Snežana B., Dugalić Branimir D.
Formato: article
Lenguaje:EN
SR
Publicado: Serbian Medical Society, Belgrade 2021
Materias:
Acceso en línea:https://doaj.org/article/6f82228eeccf4e7d9f059e3b8b021bf8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6f82228eeccf4e7d9f059e3b8b021bf8
record_format dspace
spelling oai:doaj.org-article:6f82228eeccf4e7d9f059e3b8b021bf82021-12-05T21:29:00ZEosinophilic esophagitis: A potential complication of sublingual immunotherapy0354-71322217-399410.5937/opmed2102032Khttps://doaj.org/article/6f82228eeccf4e7d9f059e3b8b021bf82021-01-01T00:00:00Zhttps://scindeks-clanci.ceon.rs/data/pdf/0354-7132/2021/0354-71322101032K.pdfhttps://doaj.org/toc/0354-7132https://doaj.org/toc/2217-3994Introduction. Eosinophilic esophagitis (EoE) represents chronic, a local immune-mediated disease with symptoms of esophageal dysfunction and histologically eosinophil-predominant inflammation and requires immediate endoscopy. Male gender is a strong risk factor. Case report. We presented a case of a 25-year-old young man with a history of allergic rhino-conjunctivitis, asthma, and intermittent severe feeding disturbance. The patient had begun sublingual immunotherapy therapy, containing specific soluble allergens for ambrosia. Six weeks after starting the ambrosia sublingual immunotherapy he developed burning epigastric pain, dysphagia, and odynophagia. Six days later, he was admitted to an emergency department due to choking on a solid of food. Esophageal histopathological findings were in favor of EoE. Sublingual immunotherapy was discontinued. He feels well now. Conclusion. The majority of cases of Eosinophilic esophagitis are diagnosed in spring or fall, 1-2 months following the peak of pollen season. Dysphagia, chest pain, food sticking, and bolus obstruction are the most common symptoms. Endoscopic findings are Schatzki ring, edema, exudates, furrows, and strictures. Six biopsies should be taken from areas with endoscopic mucosal abnormalities, and infiltration of eosinophils (more than 15 eosinophils/HRI) (HRI - high resolution imaging) is necessary for the diagnosis confirmation. Treatment options are proton pump inhibitors - oral dispersible tablets of budesonide or fluticasone propionate, an elimination diet. Sublingual immunotherapy should be discontinued. Family physicians should be aware of this complication in evaluating patients with dysphagia.Knežević Snežana B.Dugalić Branimir D.Serbian Medical Society, Belgradearticleeosinophilic esophagitisdysphagiafood bolus impactionsublingual immunotherapyMedicine (General)R5-920ENSROpšta Medicina, Vol 27, Iss 1-2, Pp 32-39 (2021)
institution DOAJ
collection DOAJ
language EN
SR
topic eosinophilic esophagitis
dysphagia
food bolus impaction
sublingual immunotherapy
Medicine (General)
R5-920
spellingShingle eosinophilic esophagitis
dysphagia
food bolus impaction
sublingual immunotherapy
Medicine (General)
R5-920
Knežević Snežana B.
Dugalić Branimir D.
Eosinophilic esophagitis: A potential complication of sublingual immunotherapy
description Introduction. Eosinophilic esophagitis (EoE) represents chronic, a local immune-mediated disease with symptoms of esophageal dysfunction and histologically eosinophil-predominant inflammation and requires immediate endoscopy. Male gender is a strong risk factor. Case report. We presented a case of a 25-year-old young man with a history of allergic rhino-conjunctivitis, asthma, and intermittent severe feeding disturbance. The patient had begun sublingual immunotherapy therapy, containing specific soluble allergens for ambrosia. Six weeks after starting the ambrosia sublingual immunotherapy he developed burning epigastric pain, dysphagia, and odynophagia. Six days later, he was admitted to an emergency department due to choking on a solid of food. Esophageal histopathological findings were in favor of EoE. Sublingual immunotherapy was discontinued. He feels well now. Conclusion. The majority of cases of Eosinophilic esophagitis are diagnosed in spring or fall, 1-2 months following the peak of pollen season. Dysphagia, chest pain, food sticking, and bolus obstruction are the most common symptoms. Endoscopic findings are Schatzki ring, edema, exudates, furrows, and strictures. Six biopsies should be taken from areas with endoscopic mucosal abnormalities, and infiltration of eosinophils (more than 15 eosinophils/HRI) (HRI - high resolution imaging) is necessary for the diagnosis confirmation. Treatment options are proton pump inhibitors - oral dispersible tablets of budesonide or fluticasone propionate, an elimination diet. Sublingual immunotherapy should be discontinued. Family physicians should be aware of this complication in evaluating patients with dysphagia.
format article
author Knežević Snežana B.
Dugalić Branimir D.
author_facet Knežević Snežana B.
Dugalić Branimir D.
author_sort Knežević Snežana B.
title Eosinophilic esophagitis: A potential complication of sublingual immunotherapy
title_short Eosinophilic esophagitis: A potential complication of sublingual immunotherapy
title_full Eosinophilic esophagitis: A potential complication of sublingual immunotherapy
title_fullStr Eosinophilic esophagitis: A potential complication of sublingual immunotherapy
title_full_unstemmed Eosinophilic esophagitis: A potential complication of sublingual immunotherapy
title_sort eosinophilic esophagitis: a potential complication of sublingual immunotherapy
publisher Serbian Medical Society, Belgrade
publishDate 2021
url https://doaj.org/article/6f82228eeccf4e7d9f059e3b8b021bf8
work_keys_str_mv AT knezevicsnezanab eosinophilicesophagitisapotentialcomplicationofsublingualimmunotherapy
AT dugalicbranimird eosinophilicesophagitisapotentialcomplicationofsublingualimmunotherapy
_version_ 1718370948477878272